ELN and triple-A syndrome: Studies have found that Il-18 receptor defect, chemokine netrin-1 deficiency, and activated transcription factor EB can reduce apoptosis of VSMCs, decrease the activity of MMP-2/9 and elastin degradation, inhibiting the occurrence and progression of AAA (118).